Martinez-Raga, Jose; Gonzalez-Saiz, Francisco; Oñate, … - In: Health Economics Review 2 (2012) 3, pp. 1-9
pharmacotherapeutic approach. Methadone has been the most widely used AOT, but buprenorphine, a partial kappa-opiod agonist and a my … methadone is 10.58; 6.98 and 7.34 in the first, second and third year respectively. Conclusion: Addition of B/N combination … would imply a maximum incremental yearly cost of 10.58 per patient compared to scenario only with methadone and would …